Table I. Clinical and pathologic information of 20 lung cancer patients.

Patients	Gender	Age	TNM stage	Differentiation	Type
1	Male	65	T2N0M0	High	LCLC
2	Male	72	T2N0M0	Middle	SCC
3	Male	69	T3N2M0	Middle	SCC
4	Male	62	T1N0M0	Middle	SCC
5	Male	52	T2N0M0	Middle	SCC
6	Male	36	T4N2M0	Middle	SCC
7	Male	47	T2N0M0	Middle	SCC
8	Male	62	T2N2M0	Middle	SCC
9	Male	39	T1N0M0	Middle	SCC
10	Male	55	T2N0M0	Low	AC
11	Male	61	T4N2M0	Low	AC
12	Male	65	T2N2M0	Low	AC
13	Female	50	T3N2M0	Middle	AC
14	Male	70	T4N2M0	High	AC
15	Male	54	T2N0M0	High	AC
16	Female	60	T2N0M0	Middle	AC
17	Male	74	T3N2M0	Low	AC
18	Male	65	T3N2M0	High	AC
19	Male	60	T2N0M0	High	SCLC
20	Female	58	T2N0M0	High	SCLC